Evidence map›Paper›PMID 40298802›Full record

ArticleAntioxidants (Basel, Switzerland)2025

Green-Synthesized Silver Nanoparticles Using

Miloš Matić, Ana Obradović, Milica Paunović, Branka Ognjanović, Vladimir Mihailović, Nikola Srećković, Milan Stanković

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Optimized CoQ10 deliveryRSC advances · 2026
    Article
  2. Green-Synthesized Silver Nanoparticles fromAntioxidants (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Miloš MatićDepartment of Biology and Ecology, Faculty of Science, University of Kragujevac, 34000 Kragujevac, Serbia.
Ana ObradovićDepartment of Biology and Ecology, Faculty of Science, University of Kragujevac, 34000 Kragujevac, Serbia.ORCID 0000-0002-6372-1062
Milica PaunovićDepartment of Biology and Ecology, Faculty of Science, University of Kragujevac, 34000 Kragujevac, Serbia.ORCID 0000-0003-1557-7497
Branka OgnjanovićDepartment of Biology and Ecology, Faculty of Science, University of Kragujevac, 34000 Kragujevac, Serbia.
Vladimir MihailovićDepartment of Chemistry, Faculty of Science, University of Kragujevac, 34000 Kragujevac, Serbia.ORCID 0000-0003-4113-6804
Nikola SrećkovićDepartment of Chemistry, Faculty of Science, University of Kragujevac, 34000 Kragujevac, Serbia.ORCID 0000-0002-0216-5816
Milan StankovićDepartment of Biology and Ecology, Faculty of Science, University of Kragujevac, 34000 Kragujevac, Serbia.ORCID 0000-0001-9861-7700

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is a leading cancer diagnosis for women around the world, with a variable degree of curability. Conventional chemotherapeutic treatments often induce toxicity and damage to healthy tissues, as well as the development of drug resistance, which is why an increasing number of new therapeutic regimens focus on the use of natural products and various modifications of their delivery to target tissues. Silver nanoparticles possess unique physicochemical characteristics, notably their increased surface area, suggesting that they hold significant potential for biomedical applications. This research evaluates the capacity of silver nanoparticles green synthesized with aqueous extracts of

Indexed as

breast cancermigrationMMP-9Nrf-2redox homeostasissilver nanoparticles

Identifiers

PMID40298802
PMCPMC12024124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.